EndoCeutics, Inc.Quebec City, Canada (NASDAQ (GM): ENCX Proposed)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

EndoCeutics Cash Flow Statement

All amounts in millions of except per share amounts.
View: Annual
Jan 07# Jan 06 Jan 05
Net Operating Cash Flow (2.5) 1.7 (2.5)
Net Investing Cash Flow (0.2) (0.6) (0.1)
Net Financing Cash Flow 1.9 (0.1) 1.6
Net Change in Cash (0.8) 1.1 (1.0)
Depreciation & Amortization -- -- --
Capital Expenditures (0.1) (0.5) (0.0)
Cash Dividends Paid 0.0 0.0 0.0